Functional characterization and m‐RNA expression of 5‐HT receptors mediating contraction in human umbilical artery

[1]  M. Rudin,et al.  Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. , 1999, The Journal of pharmacology and experimental therapeutics.

[2]  A. Brown,et al.  5‐HT1B receptor‐mediated contractions in human temporal artery: evidence from selective antagonists and 5‐HT receptor mRNA expression , 1998, British journal of pharmacology.

[3]  J. Palacios,et al.  Characterization of 5‐HT receptors on human pulmonary artery and vein: functional and binding studies , 1997, British journal of pharmacology.

[4]  M. Curtis,et al.  Involvement of 5‐HT1B/1D and 5‐HT2A receptors in 5‐HT‐induced contraction of endothelium‐denuded rabbit epicardial coronary arteries , 1997, British journal of pharmacology.

[5]  R. Purdy,et al.  Pharmacological characterization of the "silent" 5-hydroxytryptamine1B-like receptors of rabbit ear artery. , 1997, The Journal of pharmacology and experimental therapeutics.

[6]  I. Ay,et al.  5-HT1-like receptor-mediated contraction in the human internal mammary artery. , 1996, Journal of cardiovascular pharmacology.

[7]  J. Terrón,et al.  GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery. , 1996, European journal of pharmacology.

[8]  G. Martin,et al.  Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. , 1996, Trends in pharmacological sciences.

[9]  S. J. Starkey,et al.  GR127935: a potent and selective 5-HT1D receptor antagonist , 1995, Behavioural Brain Research.

[10]  M. Maclean,et al.  Contractile Responses to Sumatriptan in Isolated Bovine Pulmonary Artery Rings: Relationship to Tone and Cyclic Nucleotide Levels , 1995, Journal of cardiovascular pharmacology.

[11]  H. Lübbert,et al.  Expression of serotonin receptor mRNAs in blood vessels , 1995, FEBS letters.

[12]  F. Blaney,et al.  5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.

[13]  O. Yildiz,et al.  Amplification of responses to sumatriptan by various agonists in rabbit isolated iliac artery. , 1995, Journal of cardiovascular pharmacology.

[14]  C. Triggle,et al.  The endothelium contributes to the contractile responses of the human umbilical artery to 5-hydroxytryptamine and endothelin-1 under low but not high PO2 conditions. , 1994, Canadian journal of physiology and pharmacology.

[15]  R. Glennon,et al.  5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist. , 1994, Journal of medicinal chemistry.

[16]  H. Posival,et al.  Variable Participation of 5‐HT1‐Like Receptors and 5‐HT2 Receptors in Serotonin‐Induced Contraction of Human Isolated Coronary Arteries: 5‐HT1‐Like Receptors Resemble Cloned 5‐HT1Dβ Receptors , 1994, Circulation.

[17]  G. Higgins,et al.  Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists. , 1994, Journal of medicinal chemistry.

[18]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[19]  C. Triggle,et al.  Endothelium-independent relaxations to acetylcholine and A23187 in the human umbilical artery. , 1994, Journal of vascular research.

[20]  M. Maclean,et al.  5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone. , 1994, Pulmonary pharmacology.

[21]  C. Triggle,et al.  Tension Development, Myosin Light Chain Phosphorylation and Changes in Intracellular Free [Ca2+]i Induced by α1- and α2- Adrenoceptor Agonists , 1994 .

[22]  G. Martin Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. , 1994, Pharmacology & therapeutics.

[23]  O. Yildiz,et al.  Characterization of 5-hydroxytryptamine receptors in rabbit isolated iliac artery. , 1993, Archives internationales de pharmacodynamie et de therapie.

[24]  J. Angus,et al.  Comparison of contractile responses to 5‐hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2‐receptor agonist, U46619 , 1993, British journal of pharmacology.

[25]  J. Villemure,et al.  Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries. , 1993, Molecular pharmacology.

[26]  D. Nelson,et al.  Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor. , 1993, Molecular pharmacology.

[27]  A. Choppin,et al.  Pre-contraction with histamine and U46619 unmasks a 5-HT1-like receptor in rabbit renal artery. , 1993, European journal of pharmacology.

[28]  G. Martin,et al.  Effect of the thromboxane A2‐mimetic U46619 on 5‐HT1‐like and 5‐HT2 receptor‐mediated contraction of the rabbit isolated femoral artery , 1992, British journal of pharmacology.

[29]  T. Gudermann,et al.  Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype. , 1992, The Journal of biological chemistry.

[30]  T. Branchek,et al.  Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. S. de la Lande Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery. , 1992, British journal of pharmacology.

[32]  A. Saltzman,et al.  Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. , 1991, Biochemical and biophysical research communications.

[33]  J. McGrath,et al.  The role of endogenous thromboxane in contractions to U46619, oxygen, 5‐HT and 5‐CT in the human isolated umbilical artery , 1991, British journal of pharmacology.

[34]  D. Hoyer,et al.  5‐HT1‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of guinea‐pig isolated iliac artery , 1991, British journal of pharmacology.

[35]  E. Mylecharane Mechanisms involved in serotonin-induced vasodilatation. , 1990, Blood vessels.

[36]  A. A. Parsons,et al.  Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries. , 1989, European journal of pharmacology.

[37]  J. McGrath,et al.  5‐HT1‐like receptors requiring functional cyclo‐oxygenase and 5‐HT2 receptors independent of cyclo‐oxygenase mediate contraction of the human umbilical artery , 1989, British journal of pharmacology.

[38]  W. Feniuk,et al.  5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. , 1989, European journal of pharmacology.

[39]  A. A. Parsons,et al.  5‐HT1‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of human isolated basilar artery , 1989, British journal of pharmacology.

[40]  A. Oxford,et al.  GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous vein , 1988, British journal of pharmacology.

[41]  R. Moulds,et al.  INTERACTION BETWEEN PLATELET‐RELEASED SEROTONIN AND THROMBOXANE A2 ON HUMAN DIGITAL ARTERIES , 1986, Clinical and experimental pharmacology & physiology.

[42]  D. Reiss,et al.  Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. , 1985, The Journal of pharmacology and experimental therapeutics.

[43]  R. H. Walmsley,et al.  Manual of pharmacologic calculations with computer programs , 1982 .

[44]  T. Kenakin The Schild regression in the process of receptor classification. , 1982, Canadian journal of physiology and pharmacology.

[45]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[46]  R. Tallarida,et al.  Manual of Pharmacologic Calculations , 1981 .

[47]  R. Reiffenstein,et al.  Cocaine-induced supersensitivity in the human umbilical artery. , 1974, Canadian journal of physiology and pharmacology.

[48]  C. Reich,et al.  Effects of vasoactive agents on isolated human umbilical arteries and veins. , 1972, The American journal of physiology.

[49]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.